<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00748293</url>
  </required_header>
  <id_info>
    <org_study_id>200802030R</org_study_id>
    <nct_id>NCT00748293</nct_id>
  </id_info>
  <brief_title>Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet</brief_title>
  <official_title>Achievement of Better Examinee Compliance on Colon Cleansing Before Colonoscopy Without Sacrificing Cleansing Effect - A Multi-Center Endoscopist-Blinded Randomized Trial Using Commercialized Low-Residue Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>E-DA Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Buddhist Tzu Chi General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>En Chu Kong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Good colon cleansing is pivotal for achieving speedy and safe colonoscopic examination with&#xD;
      high adenoma detection rate.Previous studies, including our previous RCT conducted in 2004 to&#xD;
      2005, have demonstrated that high yield rate can be achieved by on-the-day colon preparation&#xD;
      with 2000 ml PEG-ELS. Poor patient compliance, however, is the main hurdle to complete&#xD;
      ingestion of 2000 ml PEG-ELS not only for subjects with lower body weight but also for those&#xD;
      with normal BMI or body weight.The main cause of poor patient compliance includes abdominal&#xD;
      pain, bloating, nausea or vomiting during ingestion of cleansing fluid.Though diet&#xD;
      restriction with low-fiber diet is always advised to every screen before colonoscopy, the&#xD;
      extent of diet restriction is widely variable and thus influences the degree of colon&#xD;
      cleansing.&#xD;
&#xD;
      With commercialized low-residue diet (CLRD), diet restriction will be well controlled and&#xD;
      variability of colon cleansing can be minimized such that guarantee a colonoscopy with good&#xD;
      quality. In this RCT, we will compare the compliance of screen during colon cleansing using&#xD;
      different protocol: namely 2000 ml PEG-ELS vs. 1500 ml plus low-residue diet.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Setting: A multi-center study including the following teaching hospitals:&#xD;
&#xD;
      National Taiwan University Hospital, Taipei Taipei Medical University Hospital, Taipei E-Da&#xD;
      Hospital, Kaohsiung Buddhist Tzu-Chi General Hospital, Taipei En Chu Kong Hospital, Taipei&#xD;
      Far Eastern Memorial Hospital, Taipei&#xD;
&#xD;
      Study design: RCT, single blinded&#xD;
&#xD;
      Study subjects:&#xD;
&#xD;
      Inclusion criteria: Subjects who receives colonoscopy for screening or for clinical purpose&#xD;
      Exclusion criteria: Subjects with polyposis, ileus, active GI bleeding, IBD, severe&#xD;
      constipation, renal insufficiency, obesity with BMI≥30&#xD;
&#xD;
      Grouping: subjects will be randomized to the following groups:&#xD;
&#xD;
        1. Group A: 2000 ml PEG-ELS&#xD;
&#xD;
        2. Group B: 1500ml PEG-ELS with CLRD Randomization process: Random block sheet&#xD;
&#xD;
      Measurements:&#xD;
&#xD;
        1. Subjects who obey protocol or violate/withdraw protocol will be all recorded.&#xD;
&#xD;
        2. Parameters concerning patient compliance&#xD;
&#xD;
        3. Number of detected adenoma and their topographical distribution&#xD;
&#xD;
        4. Time required for A. Cecal intubation B. Overall procedure time&#xD;
&#xD;
        5. Colon cleansing effect evaluation&#xD;
&#xD;
      The degree of cleansing will be recorded individually for each bowel segment (rectum, sigmoid&#xD;
      colon, descending colon, transverse colon, and ascending colon). Each segment will be rated&#xD;
      using a 5-point scale: 4, very good-colon empty and clean; 3, good-presence of clear liquid&#xD;
      in the gut; 2, moderate-presence of brown liquid or small amounts of semisolid residual&#xD;
      stool, fully removable by suction or displaceable, thus allowing a complete visualization of&#xD;
      the underlying mucosa; 1, bad-presence of semisolid stool, only partially removable with a&#xD;
      risk of incomplete underlying mucosal visualization; and 0, very bad-presence of semisolid or&#xD;
      solid stool, colonoscopy incomplete or has to be stopped. The overall quality of colonic&#xD;
      cleansing will be based on the assessment of the individual segments using a scale of A, all&#xD;
      segments clean (i.e., scores of 3 or 4 in all segments); B, residual brown liquid or&#xD;
      suctionable semisolid stool (i.e., a score of 2) in at least one segment; C, partially&#xD;
      removable stool preventing complete visualization of mucosa (i.e., a score of 1) in at least&#xD;
      one segment; or D, at least one segment can not be examined due to the presence of solid&#xD;
      stool (i.e., a score of 0). A grade of either A or B was defined, a priori, as successful&#xD;
      colon cleansing.&#xD;
&#xD;
      Sample size estimation:&#xD;
&#xD;
      Assuming 80% power and significance level at 0.05, totally at least 112 cases will be&#xD;
      required for each group (assuming 90% cases in 2000 ml achieving good or excellent&#xD;
      preparation and 76% of 1500mL plus low-residue diet achieving the same cleansing effect).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">January 2009</completion_date>
  <primary_completion_date type="Anticipated">January 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colon cleansing level</measure>
    <time_frame>At the timing of colonoscopy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>adenoma detection rate</measure>
    <time_frame>At the timing of colonoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cecal intubation time</measure>
    <time_frame>At the timing of colonoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient compliance including abdominal symptoms during colon cleansing, bowel movement on the way to hospital</measure>
    <time_frame>-2hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Whole procedural time</measure>
    <time_frame>At the timing of colonoscopy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">224</enrollment>
  <condition>Colonoscopy</condition>
  <condition>Colon Cleansing</condition>
  <condition>Low-Reside Diet</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>PEG-ELS 2000 ml ingestion in the morning of colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Low-reside diet on previous day (breakfast, lunch and dinner), PEG-ELS 1500 mL in the morning of colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low-residue diet</intervention_name>
    <description>Commercialized (not yet marketed)low-residue diet</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects who receives colonoscopy for screening or for clinical purpose&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects with polyposis, ileus, active GI bleeding, IBD, severe constipation, renal&#xD;
             insufficiency, obesity with BMI≥30&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han-Mo Chiu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Han-Mo Chiu, MD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>63354</phone_ext>
    <email>hanmochiu@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>E-DA Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chi-Yang Chang, MD</last_name>
      <email>chiyang1112@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chi-Yang Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Buddhist Tzu-Chi General Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chien-Hwa Chen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chien-Hwa Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>En Chu Kong Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chang-Shyue Yang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chang-Shyue Yang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Han-Mo Chiu, MD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>63354</phone_ext>
      <email>hanmochiu@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Han-Mo Chiu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun-Chao Chang, MD</last_name>
      <email>chunchao@tmu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Chun-Chao Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <study_first_submitted>September 5, 2008</study_first_submitted>
  <study_first_submitted_qc>September 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2008</study_first_posted>
  <last_update_submitted>September 5, 2008</last_update_submitted>
  <last_update_submitted_qc>September 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Han-Mo Chiu</name_title>
    <organization>National Taiwan Univesity Hospital</organization>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Colon cleansing</keyword>
  <keyword>Low-reside diet</keyword>
  <keyword>Compliance</keyword>
  <keyword>PEG-ELS</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

